Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7692 USD | +5.89% | -1.38% | -76.11% |
06-18 | Oppenheimer Downgrades Ovid Therapeutics to Market Perform | MT |
06-18 | B. Riley Adjusts Price Target on Ovid Therapeutics to $3 From $9, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-76.11% | 54.57M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- B. Riley Adjusts Price Target on Ovid Therapeutics to $3 From $9, Maintains Buy Rating